Science, Space and Technology News 2024
A study by Weill Cornell Medicine revealed that a nasal spray called etripamil, administered by patients at home, effectively treats rapid abnormal heart rhythms associated with paroxysmal supraventricular tachycardia , reducing the need for hospital visits. Led by Dr.
A new study has demonstrated that etripamil, a home-administered nasal spray, safely and effectively treats PSVT, a condition causing rapid heart rhythms, potentially minimizing hospital visits and invasive procedures.conducted a clinical trial that demonstrated a nasal spray could successfully and safely treat recurrent abnormal rapid heart rhythms at home, without a physician’s assistance.
The study is the latest in a series of studies by lead author Dr. James Ip, professor of clinical medicine at Weill Cornell Medicine and a cardiologist at NewYork-Presbyterian/Weill Cornell Medical Center, and colleagues to demonstrate the potential of nasal spray calcium-channel blocker etripamil as an at-home treatment PSVT. Dr. Ip received compensation as a steering committee member for Milestone Pharmaceuticals, the maker of etripamil and sponsor of the trial.
The new study enrolled 1116 patients at 148 sites in the United States, Canada and South America. It did not require a pretest dose supervised by a physician as the previous studies did. It also included patients with a history of atrial fibrillation or atrial flutter, who were excluded from the previous studies.
Reference: “Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion” by James E. Ip, Benoit Coutu, Peter A. Noseworthy, Maria L. Parody, Farhad Rafii, Samuel F. Sears, Narendra Singh, Bruce S. Stambler, David B. Bharucha and A. John Camm, 25 March 2024,SciTechDaily: Home of the best science and technology news since 1998. Keep up with the latest scitech news via email or social media.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Nasal COVID-19 Vaccine Secures Federal Funding for Groundbreaking Clinical TrialScience, Space and Technology News 2024
続きを読む »
What to know as clinical trial begins for 'next generation' nasal COVID-19 vaccineResearchers believe the nasal vaccine may be more effective than current shots.
続きを読む »
New clinical trial studies nasal COVID-19 vaccineThe candidate vaccine aims to provide enhanced protection against variants of SARS-CoV-2, the virus that causes COVID-19.
続きを読む »
Carmel woman hopeful after participating in clinical trial for new Alzheimer's drug'It gives people like me so much hope.' The FDA approved an Eli Lilly drug for people with early signs of Alzheimer’s.
続きを読む »
First Lyme Disease Vaccine in 20 Years Begins Final Clinical Trial—What You Need to KnowA new vaccine to prevent Lyme disease in humans is entering the final phase of clinical trials, manufacturers Pfizer and Valneva announced last week.
続きを読む »
Clinical Trial Of Ketamine Tablets Shows Promising Results For Treatment-Resistant DepressionAnuradha Varanasi is a freelance science writer. She writes on the intersection of health/medicine, racial disparities, and climate change. She earned an MA in Science Journalism from Columbia University in New York City.
続きを読む »